Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients.
Clara Hwang(Henry Ford Health System), Elisabeth I. Heath(The Barbara Ann Karmanos Cancer Institute), Dhananjay Chitale(Henry Ford Hospital), James O. Peabody(Henry Ford Hospital), Nilesh Gupta(Henry Ford Health System), Daryn Smith(The Barbara Ann Karmanos Cancer Institute), Mani Menon(Henry Ford Hospital), Fazlul H. Sarkar(Wayne State University), Seema Sethi(Janssen (United States)), Wael Sakr(Wayne State University), Lance K. Heilbrun(Wayne State University)
PubMed
January 1, 2016
Cited by 20
Related Papers
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells
|PLoS ONE|2010|406
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
|PubMed|2002|383
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358